Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Autor: Dharmalingam M; Endocrinology and Diabetes, Bangalore Endocrinology and Diabetes Research Centre, Bengaluru, IND., Kumar Sharma S; Diabetes and Endocrinology, Thyroid and Endocrine Centre, Jaipur, IND., Prakash V; Endocrinology, Indira Gandhi Institute of Medical Sciences, Patna, IND., Maiti A; Medicine, Kolkata Medical College, Kolkata, IND., Kumar R; Endocrinology, Diabetes and Metabolism, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND., Murthy LSS; Medicine, Life Care Hospital and Research Centre, Bengaluru, IND., Ramanathan B; Diabetes and Endocrinology, Kovai Diabetes Specialty Centre, Coimbatore, IND., Maheshwari S; Medicine, Jawaharlal Nehru Medical College, Ajmer, IND., Naik Kethavath S; Medicine, Government Medical College, Srikakulam, IND., Ogale D; Medicine, Byramjee Jeejeebhoy Medical College, Pune, IND., Bachubhai PVK; Internal Medicine, GCS Medical College, Ahmedabad, IND., Sonawane AB; Medicine, Vakratunda Hospital, Nashik, IND., Shah V; Medicine, Lifeline Multispeciality Hospital, Mumbai, IND., Suresh M; Medical Services, Micro Labs Limited, Bengaluru, IND., Chakraborty S; Medicine, Sagore Dutta Hospital, Kolkata, IND., Kumar Manjunath K; Medical Services, Micro Labs Limited, Bengaluru, IND.

Publikováno v: Cureus [Cureus] 2024 Apr 12; Vol. 16 (4), pp. e58115. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).